March 15, 2019
A shareholder in CAS Medical Systems filed a proposed class action Thursday challenging the company's pending sale to Edwards Lifesciences, saying the $100 million deal between the two medical device companies was ill-advised despite promises of bringing CASM's latest technology to a ready-made and lucrative market.